A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma.
about
Upper urinary tract disease: what we know today and unmet needsCardiopulmonary exercise testing, prehabilitation, and Enhanced Recovery After Surgery (ERAS)Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial.Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosisImpact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature.Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis.Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea.Epidermal growth factor receptor inhibitor with fluorouracil, leucovorin, and irinotecan as an alternative treatment for advanced upper tract urothelial carcinoma: a case reportEndoscopic Treatment of Upper Tract Urothelial Carcinoma.Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National University Hospital experiencePreoperative risk factors for extraurothelial recurrence in N0M0 patients with renal pelvic cancer treated by radical nephroureterectomy.Poor Preoperative Glycemic Control Is Associated with Dismal Prognosis after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Korean Multicenter Study.Perioperative treatments for resected upper tract urothelial carcinoma: a network meta-analysisThe role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study.Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.Changes in oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma treated in the last two decades: a retrospective analysis based on a multicenter collaborative study.Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract.Current role of lymphadenectomy in the upper tract urothelial carcinoma.Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality.Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.Clinical Outcomes in Patients with Panurothelial Carcinoma Treated with Radical Nephroureterectomy Following Cystectomy for Metachronous Recurrence.HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association.Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.Chemotherapy for urothelial carcinoma in renal transplantation patients: Initial results from a single center.Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis.Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.A Rare Case of Ureteral Carcinoma with Recurrence in the Duodenum Requiring Double Stenting.The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy.Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial CarcinoEfficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma.Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan.Extraurothelial recurrence after radical nephroureterectomy: preoperative predictors and survival.Upper tract urothelial carcinoma: a different disease entity in terms of management.
P2860
Q26773671-F3DAD4E8-EE7A-402B-AA6B-80887A5AA777Q28083172-8E39A7E6-2DF3-4F18-806E-B4947157DB21Q33630045-2A374139-EEAC-4C80-89D9-C224761BD643Q33817493-465E8575-7552-4133-BBE8-996A887FACF9Q34962464-1691F24D-87AD-4341-9BE2-A04C1443A863Q35180823-BB328EED-0C86-4E24-ABFA-7941A47ED3E2Q35690319-E1B5CDDA-1C82-4217-B8C0-6988A0593627Q35905142-78613CB7-6014-4B4E-A43C-448A34B3FA3AQ35993293-81829338-86D3-4673-8802-B6F0ABE1DDE5Q36294818-558E4E94-44AB-4B5B-9013-8E42F9DDF8FBQ36589221-601CA8C9-9572-42A8-A55E-47541EEE3C89Q36740908-3CEB4761-26BA-4131-BBA6-32417A79F9F5Q37367482-504B61E0-4C79-434F-B2E6-929766D15118Q37709517-D5002E1C-8558-4EE3-BD57-322CD1FBBE54Q38211604-B9322EE5-D382-437F-BCC0-39617D64CB7EQ38784315-FE3DB90F-B47D-4C51-B2D6-4AF3DB8D5C0DQ38941344-963A768F-6A8C-4992-A897-6B49992D3344Q38984138-29D3BDA2-DCEE-44B9-9D01-73E04B70F491Q38996283-233694B7-0E1C-486D-A12F-5234C3BFE8D6Q39078873-413072D1-0B28-4A0E-9C9C-9C88A1C91809Q39406932-FA31964F-02C8-45CC-A572-040E10414EFAQ39865101-EFF85B08-CE2B-48DF-8B19-E78B60D6633FQ39953451-067B351A-E6EA-41FA-9F48-2575D490A5E3Q40273591-AB63A51A-AC44-4A94-B3F6-4E30635E5B79Q40713928-9236C029-A5A3-41EB-8171-94D1C267AC04Q40798009-12E0E7AC-D740-4E97-9FAE-10C3C8B22160Q40925557-56349BF5-E29C-4343-887C-0D31A775314FQ41604549-41FD2A5D-EA6E-4200-8B6C-690988603AFDQ43148268-D42DB390-F84D-474E-A147-7BAD1275538CQ47108017-A720E138-360E-4DD1-8CC3-6F068FAAE7C4Q47134826-D99A0510-25E7-490D-9B2F-A4989456F9D7Q47164284-D0C6C1AF-761D-4BF2-9F0A-B986DFB75192Q47367089-8D0FFFE5-D300-49F5-8FDA-8C4E76A3A487Q47936737-C50FEBEC-E616-4556-9EB2-EC084C410953Q48293327-B72B9A94-5F54-4BA7-B85D-52DE109E0281Q49543774-694090FE-771A-4A8A-8E98-B127B59B942FQ50055581-87F30500-14F5-49ED-8A4D-C02F52723723Q50801479-22F24AFB-0990-4CB9-B4AE-803DE16AA5BBQ53578286-19645498-7E35-4953-882A-6B7512F48678Q54493905-E6AB9E2E-9C30-4916-A796-CA60A8A73A65
P2860
A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A systematic review and meta-a ...... er tract urothelial carcinoma.
@en
type
label
A systematic review and meta-a ...... er tract urothelial carcinoma.
@en
prefLabel
A systematic review and meta-a ...... er tract urothelial carcinoma.
@en
P2093
P1433
P1476
A systematic review and meta-a ...... er tract urothelial carcinoma.
@en
P2093
André P Fay
Jeffrey J Leow
Joaquim Bellmunt
Steven L Chang
Toni K Choueiri
William Martin-Doyle
P304
P356
10.1016/J.EURURO.2014.03.003
P407
P577
2014-03-16T00:00:00Z